The most potent GHRH analog in clinical use.
Tesamorelin is a modified GHRH analog. Its brand version (Egrifta) is FDA-approved for a specific indication; Pepvio’s compounded version is prescribed off-label by licensed providers for patients assessed during intake.
2 minutes · No commitment · $699/mo if approved
Researching the premium tier of GHRH analog protocols
Interested in the peptide with published body-composition trial data
Evaluating escalation from a Sermorelin protocol
Looking for a physician-supervised protocol with quarterly labs
Based on an FDA-approved molecule (Egrifta); Pepvio’s version is a compounded formulation prescribed off-label
Published clinical trial data on body composition endpoints
Physician-supervised protocol with quarterly lab monitoring
Eligibility and dosing determined during intake by a licensed provider
What's in this protocol
Tesamorelin
1-2mg daily, subcutaneous injection
A potent GHRH analog that is currently FDA-approved (Egrifta) for visceral adipose tissue reduction. Prescribed off-label by longevity clinicians for body composition and metabolic optimization.
Flexible payment options available at checkout · Cancel anytime
Ready to start?
Take a free 2-minute assessment. If a licensed provider approves your protocol, your medication ships directly to your door. Not approved? Your card is never charged.
Start Free AssessmentThese statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. All prescription medications require a valid prescription from a licensed healthcare provider.